-- Apple, Bio-Rad, Cherokee, Clovis, GM: U.S. Equity Movers
-- B y   L u   W a n g
-- 2012-04-03T20:20:41Z
-- http://www.bloomberg.com/news/2012-04-02/cavium-pep-boys-sigma-aldrich-u-s-equity-preview.html
Shares of the following companies
had unusual moves in U.S. trading. Stock symbols are in
parentheses, and prices are as of 4 p.m. in  New York .  Commodity producers declined as a report showed factory
orders rose less than economists estimated and minutes from the
 Federal Reserve ’s latest policy meeting damped expectations for
more monetary stimulus.  Valero Energy Corp. (VLO)   slipped 3.5 percent to $25.40.
 Alpha Natural Resources Inc. (ANR)   retreated 5 percent to
$14.69.  Nabors Industries Ltd. (NBR)   fell 2.3 percent to
$17.19.  Apple Inc. (AAPL)   advanced 1.7 to a record price of
$629.32. The world’s most valuable company could surge to $1,000
by 2014,  Gene Munster , an analyst at Piper Jaffray Cos., said in
a note to clients today. He raised his 12-month price target to
$910 from $718.  Brian White , an analyst at Topeka Capital
Markets, yesterday set an estimate of $1,001.  Bio-Rad Laboratories Inc. (BIO)   climbed 11 percent, the
most since November 2008, to $114.25. The maker of laboratory
equipment was granted global sales and distribution rights for
Luminex Corp’s (LMNX US) Magpix multiplexing instrument.
Separately, the company said its Chairman and Co-founder David
Schwartz died at the age of 88.  Cherokee Inc. (CHKE)   advanced 13 percent, the most since
March 2009, to $12.67. The brand management company agreed with
Tesco to re-introduce Cherokee brand casual clothing in the
second half of this year.  Clovis Oncology Inc. (CLVS)   fell 13 percent, the most
since its initial public offering in November, to $20.86. The
biopharmaceutical company may price an offering of as much as
$75 million shares after the close of exchanges today.  Conn’s Inc. (CONN)   surged 16 percent to $19.05 for the
biggest gain in the Russell 2000 Index. The Beaumont, Texas-
based consumer electronics retailer raised its fiscal 2013
earnings forecast to at least $1.20 a share, compared with the
average analyst projection for $1.11, data compiled by Bloomberg
show.  Constellation Brands Inc. (STZ)   rose 2.3 percent to
$24.50, the highest price since December 2007. The world’s
largest wine company was raised to buy from neutral at Goldman
Sachs Group Inc.  CVR Energy Inc. (CVI)   gained 5.9 percent to $28.80, the
highest price since Feb. 27. Billionaire investor Carl Icahn
extended to April 30 the deadline for his unsolicited offer for
the producer of refined products and fertilizer, after 55
percent of shares were tendered under his $30-a-share bid for
the company.  General Motors Co. (GM)   dropped 4.6 percent, the most
since March 6, to $25.54. The automaker, with its premium brands
losing ground, posted gains in U.S. vehicle sales that trailed
analysts’ estimates.  Merge Healthcare Inc. (MRGE)   fell 16 percent, the most
since November 2008, to $4.95. The medical imaging provider
entered a $2.75 million health-kiosk agreement with Higi LLC,
controlled by Merge Chairman Michael W. Ferro Jr., according to
a regulatory filing.  Mitek Systems Inc. (MITK)   dropped 11 percent to $8.34,
the lowest price since Feb. 2. USAA filed a suit against the
software developer in U.S. District Court in  San Antonio ,
alleging misappropriation of proprietary information, breach of
contract and fraud, among other claims. Mitek, which has a
software license agreement with the provider of financial
services to members of the U.S. military, said the claims are
“without merit.”  Molson Coors Brewing Co. (TAP)   fell 5.4 percent, the
most since May 3, to $43.18. The U.S. maker of Carling lager
agreed to buy StarBev LP for 2.65 billion euros ($3.54 billion)
to add beer brands such as Staropramen and provide a route into
central and eastern  Europe .  Navidea Biopharmaceuticals Inc. (NAVB)   declined 11
percent, the most since Aug. 10, to $2.94. The Dublin, Ohio-
based developer of diagnostics for cancer said the U.S. Food and
Drug Administration’s review of Lymphoseek was extended three
months after the company submitted updated information, at the
FDA’s request.  Solazyme Inc. (SZYM)   rose 12 percent, the most since
Nov. 16, to $16.03. The maker of oil products from genetically
modified algae formed a joint venture with  Bunge Ltd. (BG)  
for a commercial-scale renewable tailored oils production
facility in Brazil.  Uranium Energy Corp. (UEC)   fell 12 percent, the most
since Oct. 3, to $3.38. The developer of a mine in Texas said it
plans to sell as many as 5.6 million shares at $3.60 each.  Urban Outfitters Inc. (URBN)   gained 2.3 percent to
$30.22, the highest price since Aug. 3. The operator of its
namesake, Anthropologie and Free People brands was raised to
neutral from sell at Citigroup Inc.  To contact the reporter on this story:
 Lu Wang  in New York at   lwang8@bloomberg.net .  To contact the editor responsible for this story:
Nick Baker at 
 nbaker7@bloomberg.net  